Arcturus Therapeutics Competitors and Similar CompaniesClear all

Arcturus Therapeutics's competitors and similar companies include Vertex Pharmaceuticals, Horizon Therapeutics, SalioGen Therapeutics and Glixis Therapeutics.
Arcturus Therapeutics
Arcturus Therapeutics
Arcturus Therapeutics is a preclinical drug delivery and nucleic acid medicines company.
Vertex Pharmaceuticals
Vertex Pharmaceuticals
Vertex Pharmaceuticals is a biotechnology company that focuses on discovering, developing, and producing medicines.
Horizon Therapeutics
Horizon Therapeutics
Horizon Therapeutics (formerly known as Horizon Pharma) is a biopharmaceutical company focused on researching, developing, and commercializing medicines.
SalioGen Therapeutics
SalioGen Therapeutics
SalioGen Therapeutics is a company developing genetic medicine.
Glixis Therapeutics
Glixis Therapeutics
Glixis Therapeutics is a company providing therapies for autoimmune diseases.
Founding Date
Founding Date
2013
Founding Date
1989
Founding Date
2008
Founding Date
2020
Founding Date
2012
Type
Type
Public
Type
Public
Type
Subsidiary
Type
Private
Type
Private
Tags
Locations
Locations
San Diego, US HQ
Locations
Boston, US HQ
St Leonards, AU
Wien, AT
Bruxelles, BE
São Paulo, BR
Toronto, CA
Praha, CZ
see more
Locations
Dublin, IE HQ
Locations
Cambridge, US HQ
Woburn, US
Locations
HQ
Employees
Employees
170
Employees
5,40013% increase
Employees
2,662
Employees
761% decrease
Employees
3
Valuation ($)
Valuation ($)
529.2 m
Valuation ($)
121.4 b
Valuation ($)
N/A
Valuation ($)
N/A
Valuation ($)
N/A

Financial

Revenue (est.)
Revenue (est.)
$82m (FY, 2025)
Revenue (est.)
$12b (FY, 2025)
Revenue (est.)
$3.6b (FY, 2022)
Revenue (est.)
N/A
Revenue (est.)
N/A
Cost of goods
Cost of goods
N/A
Cost of goods
$1.7b (FY, 2025)
Cost of goods
$920.2m (FY, 2022)
Cost of goods
N/A
Cost of goods
N/A
Gross profit
Gross profit
N/A
Gross profit
$10.4b (FY, 2025)
Gross profit
$2.7b (FY, 2022)
Gross profit
N/A
Gross profit
N/A
Net income
Net income
($65.8m) (FY, 2025)
Net income
N/A
Net income
$521.5m (FY, 2022)
Net income
N/A
Net income
N/A

Operating

Products
Products
N/A
Products
6 (FY, 2022)
Products
11 (FY, 2020)
Products
N/A
Products
N/A

Funding

Total funding raised
Total funding raised
N/A
Total funding raised
$ 2.4m
Total funding raised
$ 63m
Total funding raised
$ 135m
Total funding raised
N/A
For sources of this data, please see the company profile

View Company Profiles

Vertex Pharmaceuticals
HQ
Boston, US
Employees
5,400↑ 13% increase

Vertex Pharmaceuticals is a biotechnology company that focuses on discovering, developing, and producing medicines.

View company
Horizon Therapeutics
HQ
Dublin, IE

Horizon Therapeutics (formerly known as Horizon Pharma) is a biopharmaceutical company focused on researching, developing, and commercializing medicines.

View company
SalioGen Therapeutics
HQ
Cambridge, US
Employees
76↓ 1% decrease

SalioGen Therapeutics is a company developing genetic medicine.

View company
Glixis Therapeutics
HQ
Employees
3

Glixis Therapeutics is a company providing therapies for autoimmune diseases.

View company